| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0020-711X(80)90229-3 |
| P698 | PubMed publication ID | 7389984 |
| P2093 | author name string | G. M. Kostner | |
| E. Polz | |||
| H. Wurm | |||
| P433 | issue | 3-4 | |
| P921 | main subject | lipoprotein | Q28350 |
| P304 | page(s) | 265–270 | |
| P577 | publication date | 1980-01-01 | |
| P1433 | published in | International Journal of Biochemistry & Cell Biology | Q6051320 |
| P1476 | title | Investigations on beta 2-glycoprotein-I in the rat: isolation from serum and demonstration in lipoprotein density fractions | |
| P478 | volume | 11 |
| Q33350227 | A new player in the antiphospholipid syndrome: the beta 2 glycoprotein I cofactor |
| Q33488617 | Activation of cultured vascular endothelial cells by antiphospholipid antibodies. |
| Q64097620 | Adenosine receptor agonism protects against NETosis and thrombosis in antiphospholipid syndrome |
| Q37283042 | Annexin A2: biology and relevance to the antiphospholipid syndrome |
| Q71018619 | Anti beta 2-glycoprotein I antibodies in a patient with catastrophic antiphospholipid syndrome |
| Q53316978 | Anti-cardiolipin, anti-cardiolipin plus bovine, or human beta(2)glycoprotein-I and anti-human beta(2)glycoprotein-I antibodies in a healthy infant population. |
| Q33502295 | Anti-mitochondrial M5 type antibody represents one of the serological markers for anti-phospholipid syndrome distinct from anti-cardiolipin and anti-beta2-glycoprotein I antibodies |
| Q24558202 | Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H) |
| Q53325327 | Anticardiolipin and anti-beta(2) glycoprotein I antibodies in sera of 61 apparently healthy children at regular preventive visits. |
| Q36222874 | Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I. |
| Q45763284 | Antiphospholipid antibodies differ in aPL cofactor requirement |
| Q41682862 | Antiphospholipid antibodies or not? The role of beta 2 glycoprotein 1 in autoantibody-mediated pregnancy loss |
| Q36881604 | Antiphospholipid antibodies: effects on trophoblast and endothelial cells |
| Q52008946 | Behavioral and cognitive deficits occur only after prolonged exposure of mice to antiphospholipid antibodies. |
| Q41921283 | Characterization of binding of human beta 2-glycoprotein I to cardiolipin |
| Q70307760 | Characterization of the interaction between β2-glycoprotein i and mitochondria, platelets, liposomes and bile acids |
| Q34659598 | Coagulopathy triggered autoimmunity: experimental antiphospholipid syndrome in factor V Leiden mice |
| Q41674799 | Complete nucleotide and deduced amino acid sequence of human β2-glycoprotein I |
| Q36971284 | Comprehensive evaluation of apolipoprotein H gene (APOH) variation identifies novel associations with measures of lipid metabolism in GENOA. |
| Q72002718 | Detection of anti-bovine ?2-glycoprotein I antibody in sera from patients with antiphospholipid syndrome |
| Q45902619 | Effects of ionic strength, temperature and conformation on affinity interactions of β₂-glycoprotein I monitored by capillary electrophoresis. |
| Q84312482 | Estimation of the amount of β2-glycoprotein I adsorbed at the inner surface of fused silica capillaries after acidic, neutral and alkaline pretreatment |
| Q42099603 | Heparin-binding apoproteins. Effects on lipoprotein lipase and hepatic uptake of remnants |
| Q22254095 | High affinity binding of beta 2-glycoprotein I to human endothelial cells is mediated by annexin II |
| Q36157442 | Identification of a region of beta 2-glycoprotein I critical for lipid binding and anti-cardiolipin antibody cofactor activity |
| Q73424843 | Identification of beta2-glycoprotein I as a membrane-associated protein in kidney: purification by calmodulin affinity chromatography |
| Q35822651 | Induction of antiphospholipid autoantibodies by immunization with beta 2 glycoprotein I (apolipoprotein H). |
| Q72873820 | Induction of phospholipid-binding antibodies in mice and rabbits by immunization with human beta 2 glycoprotein 1 or anticardiolipin antibodies alone |
| Q33498334 | Isolation and purification of anticardiolipin antibody from plasma of a patient with antiphospholipid syndrome: induced generation of platelet thromboxane A2 synthesis |
| Q33237339 | Molecular cloning and mammalian expression of human beta 2-glycoprotein I cDNA. |
| Q77796443 | Opposite beta2-glycoprotein I requirement for the binding of infectious and autoimmune antiphospholipid antibodies to cardiolipin liposomes is associated with antibody avidity |
| Q33499192 | Phospholipid binding plasma proteins required for antiphospholipid antibody detection--an overview |
| Q57372547 | Plasma Protein β-2-Glycoprotein 1 Mediates Interaction between the Anti-tumor Monoclonal Antibody 3G4 and Anionic Phospholipids on Endothelial Cells |
| Q33706238 | Platelet microparticles: a wide-angle perspective |
| Q37590447 | Potential roles of cell-derived microparticles in ischemic brain disease |
| Q43677862 | Prevalence and isotype distribution of antiphospholipid antibodies in Chilean patients with systemic lupus erythematosus (SLE). |
| Q47877215 | Prevalence and isotype distribution of antiphospholipid antibodies in unselected Chilean patients with venous and arterial thrombosis |
| Q33372577 | Prevalence of antiphospholipid antibodies in Chilean patients with rheumatoid arthritis. |
| Q58421416 | Prevalence of lupus anticoagulant in patients with cirrhosis: relationship with beta-2-glycoprotein I plasma levels |
| Q31920894 | Structure of the human beta2-glycoprotein I (apolipoprotein H) gene. |
| Q24302454 | Studies on the possible function of beta 2-glycoprotein-I: influence in the triglyceride metabolism in the rat |
| Q41101472 | Synthesis of beta2 glycoprotein 1 by the human placenta |
| Q36745091 | Targeted Proteomics Identifies Paraoxonase/Arylesterase 1 (PON1) and Apolipoprotein Cs as Potential Risk Factors for Hypoalphalipoproteinemia in Diabetic Subjects Treated with Fenofibrate and Rosiglitazone |
| Q42224647 | The insertion of human apolipoprotein H into phospholipid membranes: a monolayer study |
| Q36639649 | The interaction of beta(2)-glycoprotein I domain V with chaperonin GroEL: the similarity with the domain V and membrane interaction |
| Q61711988 | Val/Leu247 and Trp/Ser316 polymorphisms in β2 glycoprotein I and their association with thrombosis in unselected Chilean patients |
| Q73300653 | beta(2)-glycoprotein I-dependent alterations in membrane properties |
| Q71823763 | β2-Glycoprotein I Is a Major Protein Associated with Very Rapidly Cleared Liposomes in Vivo, Suggesting a Significant Role in the Immune Clearance of “Non-self” Particles |
Search more.